A heart transplant is an operation in which a diseased or failing heart is removed and replaced with a healthy donor organ. It is reserved for people with advanced heart failure or other cardiac conditions that do not respond to medical or less invasive treatments. The procedure itself is complex and requires coordination among surgeons, anesthesiologists, intensive care teams and organ allocation services; it is a type of surgery that combines technical skill with long-term medical management.
When and why it is used
Typical indications include end-stage heart failure with severe symptoms despite optimal therapy, certain congenital heart diseases, and some cases of severe cardiomyopathy. Candidates are evaluated for overall health, ability to tolerate surgery, and likelihood of adhering to lifelong follow-up and immunosuppressive therapy. Not every patient with heart disease is suitable; factors such as active infection, some cancers, and certain other medical problems can be contraindications.
Procedure and immediate care
The operation involves removing the recipient's failing heart and implanting the donor heart, connecting major blood vessels and ensuring the new organ is functioning. After surgery, patients remain in intensive care for close monitoring of hemodynamics, graft function and complications. Early management focuses on preventing infection, monitoring for rejection and supporting other organs while the body adapts to the transplant.
Immunosuppression and rejection
To prevent the immune system from attacking the donor heart, patients take a combination of immunosuppressive drugs for life. These medications reduce rejection risk but increase vulnerability to infections and some long-term side effects. Rejection can be acute or chronic; surveillance typically includes clinical assessment, imaging and tissue sampling when indicated. Prompt recognition and treatment of rejection are essential for graft survival.
Risks, outcomes and alternatives
- Common complications: rejection, infection, bleeding, organ dysfunction and complications related to immunosuppression.
- Long-term issues: chronic graft vasculopathy, renal impairment and medication side effects.
- Alternatives: mechanical circulatory support such as ventricular assist devices (VADs) and, in some settings, palliative care.
History and notable facts
The first successful human heart transplant was performed in December 1967 by surgeon Christiaan Barnard, an event often cited as a milestone in transplant medicine; earlier experimental work and animal research paved the way. Donor hearts typically come from deceased donors who meet strict criteria to ensure organ viability. Allocation systems and ethical frameworks guide how donor hearts are matched and distributed to recipients.
Importance and ongoing developments
Heart transplantation remains a life-saving option for selected patients with end-stage cardiac disease. Research continues on improving organ preservation, reducing rejection, expanding donor pools, and developing mechanical and biological alternatives. For more clinical details and patient resources, consult specialist centers and transplant programs (first human heart transplant reports and program information are available) and professional guidelines for up-to-date recommendations (surgical and medical care resources).